Reversal of human cellular senescence: roles of the p53 and p16 pathways
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Telomere erosion and subsequent dysfunction limits the proliferation of normal human cells by a process termed replicative senescence. Replicative senescence is thought to suppress tumorigenesis by establishing an essentially irreversible growth arrest that requires activities of the p53 and pRB tumor suppressor proteins. We show that, depending on expression of the pRB regulator p16, replicative senescence is not necessarily irreversible. We used lentiviruses to express specific viral and cellular proteins in senescent human fibroblasts and mammary epithelial cells. Expression of telomerase did not reverse the senescence arrest. However, cells with low levels of p16 at senescence resumed robust growth upon p53 inactivation, and limited growth upon expression of oncogenic RAS. In contrast, cells with high levels of p16 at senescence failed to proliferate upon p53 inactivation or RAS expression, although they re-entered the cell cycle without growth after pRB inactivation. Our results indicate that the senescence response to telomere dysfunction is reversible and is maintained primarily by p53. However, p16 provides a dominant second barrier to the unlimited growth of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p16, an inhibitor of CDK4 and CDK6, is also key in several types of senescence26; p21 is activated early on senescence entry and p16 is activated later, probably to maintain the senescence phenotype27”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, cells that express low p16 INK4a levels (e.g., SEN(REP) or SEN(XRA) HCA2) senesce in response to severe damage by activating the p53 pathway; when p53 is subsequently inactivated in these cells, they resume proliferation [ 62 ], but do not lose the SASP.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This accumulation results in persistent activation of RB family proteins, inhibition of E2F transactivation, and consequent cell-cycle arrest, which, in time, cannot be reversed by subsequent inactivation of RB family proteins or p53 (Beause ´ jour et al., 2003).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In senescent cells, however, the CDK2 inhibitor p21 WAF1/Cip1 ( CDKN1A ) and CDK4/6 inhibitor p16 INK4A ( CDKN2A ) accumulate.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell cycle controlling proteins p16, p21, and p53, normally inhibit cell cycle progression and have been shown to be accumulated in senescent cells [49–51].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [51]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Self-citationSwitching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Cited by
Items 401–500 of 1,003
Insulin-like growth factor-1 signaling in cardiac aging
Lee, W. S., & Kim, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.029 · Cited by 74
Galectin-1 in Melanoma Biology and Related Neo-Angiogenesis Processes
Mathieu, V., de Lassale, E. M., Toelen, J., Mohr, T. T., Bellahcène, A., Goietsenoven, G. V., Verschuere, T., Bouzin, C., Debyser, Z., Vleeschouwer, S. D., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.142 · Cited by 68
Książek, K., Piwocka, K., Brzezińska, A., Sikora, E., Zabel, M., Bręborowicz, A., Jörres, A., & Witowski, J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01086.2005 · Cited by 73
Choi, M., In, Y.-H., Park, J., Park, T., Jung, K. H., Chai, J. C., Chung, M. K., Lee, Y. S., & Chai, Y. G. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.8.057 · Cited by 73
Downregulation of APE1/Ref-1 Is Involved in the Senescence of Mesenchymal Stem Cells
Heo, J. Y., Jing, K., Song, K., Seo, K.-S., Park, J., Kim, J.-S., Jung, Y.-J., Hur, G.-M., Jo, D.-Y., Kweon, G.-R., et al. (2009) · Stem Cells · doi:10.1002/stem.54 · Cited by 74
At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity
Rizzotto, D., Englmaier, L., & Villunger, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910883 · Cited by 75
p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression
Zheng, H., Chen, L., Pledger, W. J., Fang, J., & Chen, J. (2014) · Oncogene · doi:10.1038/onc.2013.6 · Cited by 66
Interferon-γ Induces Senescence in Normal Human Melanocytes
Wang, S., Zhou, M., Lin, F., Liu, D., Hong, W., Lu, L., Zhu, Y., & Xu, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093232 · Cited by 75
Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
Le Duff, M., Gouju, J., Jonchère, B., Guillon, J., Toutain, B., Boissard, A., Henry, C., Guette, C., Lelièvre, E., & Coqueret, O. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0209-y · Cited by 64
Stress granules counteract senescence by sequestration of PAI‐1
Omer, A., Patel, D. M., Lian, X. J., Sadek, J., Marco, S. D., Pause, A., Gorospe, M., & Gallouzi, I. (2018) · EMBO Reports · doi:10.15252/embr.201744722 · Cited by 71
The emerging role of cellular senescence in renal diseases
Zhou, B., Wan, Y., Chen, R., Zhang, C., Li, X., Meng, F., Glaser, S., Wu, N., Zhou, T., Li, S., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14952 · Cited by 64
Cell Senescence, Multiple Organelle Dysfunction and Atherosclerosis
Machado-Oliveira, G., Ramos, C., Marques, A. R. A., & Vieira, O. V. (2020) · Cells · doi:10.3390/cells9102146 · Cited by 80
Liu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
A role for WRN in telomere-based DNA damage responses
Eller, M. S., Liao, X., Liu, S., Hanna, K., Bäckvall, H., Opresko, P. L., Bohr, V. A., & Gilchrest, B. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607332103 · Cited by 66
Giuliani, A., Prattichizzo, F., Micolucci, L., Ceriello, A., Procopio, A. D., & Rippo, M. R. (2017) · Mediators of Inflammation · doi:10.1155/2017/2309034 · Cited by 73
Senescence in polyploid giant cancer cells: A road that leads to chemoresistance
Bharadwaj, D., & Mandal, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.11.002 · Cited by 64
p53 in senescence – it's a marathon, not a sprint
Sheekey, E., & Narita, M. (2021) · FEBS Journal · doi:10.1111/febs.16325 · Cited by 66
Self-citationThe controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy
Cao, L., Li, K., Li, Q., Tong, Q., Wang, Y., & Huang, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02475-8 · Cited by 93
Tristetraprolin: Roles in cancer and senescence
Ross, C. R., Brennan-Laun, S. E., & Wilson, G. M. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.005 · Cited by 64
Burton, D. G. A., Giribaldi, M. G., Muñoz, A., Halvorsen, K. T., Patel, A., Jordà, M., Perez‐Stable, C., & Rai, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068003 · Cited by 73
Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway
He, L., Chen, Y., Feng, J., Sun, W., Li, S., Ou, M., & Tang, L. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.007 · Cited by 67
Epigenetic Basis of Cellular Senescence and Its Implications in Aging
Nacarelli, T., Liu, P., & Zhang, R. (2017) · Genes · doi:10.3390/genes8120343 · Cited by 63
Hyperoxia‐induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS
Klimova, T. A., Bell, E. L., Shroff, E. H., Weinberg, F. D., Snyder, C. M., Dimri, G. P., Schumacker, P. T., Budinger, G. R. S., & Chandel, N. S. (2009) · The FASEB Journal · doi:10.1096/fj.08-114256 · Cited by 63
Rapamycin, proliferation and geroconversion to senescence
Blagosklonny, M. V. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1554781 · Cited by 62
TP53 in Biology and Treatment of Osteosarcoma
Synoradzki, K. J., Bartnik, E., Czarnecka, A. M., Fiedorowicz, M., Firlej, W., Brodziak, A., Stasinska, A., Rutkowski, P. L., & Grieb, P. (2021) · Cancers · doi:10.3390/cancers13174284 · Cited by 70
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Battram, A. M., Bachiller, M., & Martín-Antonio, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124346 · Cited by 70
Senolytic targets and new strategies for clearing senescent cells
Ge, M., Hu, L., Ao, H.-S., Zi, M., Kong, Q., & He, Y. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111468 · Cited by 67
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 65
Detection of the Senescence-Associated Secretory Phenotype (SASP)
Rodier, F. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_10 · Cited by 60
Helmbold, H., Komm, N., Deppert, W., & Bohn, W. (2009) · Oncogene · doi:10.1038/onc.2009.222 · Cited by 68
ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein
Boulay, P.-L., Schlienger, S., Lewis-Saravalli, S., Vitale, N., Ferbeyre, G., & Claing, A. (2011) · Oncogene · doi:10.1038/onc.2011.100 · Cited by 61
Heathfield, S. K., Maitre, C. L. L., & Hoyland, J. A. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2468 · Cited by 67
Cellular senescence and protein degradation: Breaking down cancer
Deschênes-Simard, X., Lessard, F., Gaumont-Leclerc, M.-F., Bardeesy, N., & Ferbeyre, G. (2014) · Cell Cycle · doi:10.4161/cc.29335 · Cited by 61
Cellular senescence in ionizing radiation (Review)
Chen, Z., Cao, K., Xia, Y., Li, Y., Hou, Y., Wang, L., Li, L., Chang, L., & Li, W. (2019) · Oncology Reports · doi:10.3892/or.2019.7209 · Cited by 85
The Emerging Role of Senescence in Ocular Disease
Sreekumar, P. G., Hinton, D. R., & Kannan, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2583601 · Cited by 61
Therapy-induced polyploidization and senescence: Coincidence or interconnection?
Sikora, E., Czarnecka‐Herok, J., Bojko, A., & Sunderland, P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.015 · Cited by 68
Telomere dysfunction and cell survival: roles for distinct TIN2-containing complexes
Kim, S.-H., Davalos, A. R., Heo, S.-J., Rodier, F., Zou, Y., Beausejour, C., Kaminker, P., Yannone, S. M., & Campisi, J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710028 · Cited by 61
Self-citationA hydride transfer complex reprograms NAD metabolism and bypasses senescence
Igelmann, S., Lessard, F., Uchenunu, O., Bouchard, J., Fernandez-Ruiz, A., Rowell, M.-C., Lopes-Paciencia, S., Papadopoli, D., Fouillen, A., Ponce, K. J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.028 · Cited by 60
p16INK4a‐induced senescence is disabled by melanoma‐associated mutations
Haferkamp, S., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00422.x · Cited by 59
Reddy, J. P., Peddibhotla, S., Bu, W., Zhao, J., Haricharan, S., Du, Y. N., Podsypanina, K., Rosen, J. M., Donehower, L. A., & Li, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910665107 · Cited by 63
An, S., Cho, S.-Y., Kang, J., Lee, S., Kim, H.-S., Min, D.-J., Son, E., & Cho, K.-H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920338117 · Cited by 60
Roles of Apoptosis and Cellular Senescence in Cancer and Aging
Cerella, C., Grandjenette, C., Dicato, M. A., & Diederich, M. F. (2016) · Current Drug Targets · doi:10.2174/1389450116666150202155915 · Cited by 71
Chen, J., Ozanne, S. E., & Hales, C. N. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.06.003 · Cited by 64
Malaquin, N., Vancayseele, A., Gilbert, S., Antenor-Habazac, L., Olivier, M.-A., Ait Ali Brahem, Z., Saad, F., Delouya, G., & Rodier, F. (2020) · Cells · doi:10.3390/cells9071593 · Cited by 59
Cellular Senescence in Liver Disease and Regeneration
Ferreira-Gonzalez, S., Rodrigo-Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 59
Aging and endothelin: Determinants of disease
Barton, M. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.09.009 · Cited by 58
Repeated stimulation by LPS promotes the senescence of DPSCs via TLR4/MyD88-NF-κB-p53/p21 signaling
Feng, G., Zheng, K., Cao, T., Zhang, J., Lian, M., Huang, D., Wei, C., Gu, Z., & Feng, X. (2018) · Cytotechnology · doi:10.1007/s10616-017-0180-6 · Cited by 68
The Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 69
In vitro lifespan and senescence mechanisms of human nucleus pulposus chondrocytes
Jeong, S.-W., Lee, J., & Kim, K.-W. (2013) · The Spine Journal · doi:10.1016/j.spinee.2013.06.099 · Cited by 65
Bolesta, E., Pfannenstiel, L. W., Demelash, A., Lesniewski, M. L., Tobin, M., Schlanger, S. E., Nallar, S. C., Papadimitriou, J. C., Kalvakolanu, D. V., & Gastman, B. R. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06214-11 · Cited by 58
Role of Sirt1 Plays in Nucleus Pulposus Cells and Intervertebral Disc Degeneration
Guo, J., Shao, M., Lu, F., Jiang, J., & Xia, X. (2016) · Spine · doi:10.1097/brs.0000000000001954 · Cited by 58
Emerging roles of CST in maintaining genome stability and human disease
Stewart, J. A., Wang, Y., Ackerson, S. M., & Schuck, P. L. (2018) · Frontiers in bioscience · doi:10.2741/4661 · Cited by 60
Senescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 64
Cellular senescence: a double‐edged sword in the fight against cancer
Ohtani, N., Takahashi, A., Mann, D. J., & Hara, E. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01493.x · Cited by 57
The yin and yang of the Cdkn2a locus in senescence and aging
Baker, D. J., Jin, F., & van Deursen, J. M. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6687 · Cited by 56
Epithelial proliferation and cell cycle dysregulation in kidney injury and disease
Lee, K., Gusella, G. L., & He, C. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.024 · Cited by 60
Analysis of Tumor Suppressor Genes Based on Gene Ontology and the KEGG Pathway
Yang, J., Chen, L., Kong, X., Huang, T., & Cai, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107202 · Cited by 60
Senescence and tumor suppression
Hinds, P., & Pietruska, J. (2017) · F1000Research · doi:10.12688/f1000research.11671.1 · Cited by 57
Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization
May, T., Hauser, H., & Wirth, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh887 · Cited by 67
Brandhagen, B. N., Tieszen, C. R., Ulmer, T. M., Tracy, M. S., Goyeneche, A. A., & Telleria, C. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-35 · Cited by 60
Nek4 Regulates Entry into Replicative Senescence and the Response to DNA Damage in Human Fibroblasts
Nguyen, C. L., Possemato, R., Bauerlein, E. L., Xie, A., Scully, R., & Hahn, W. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00436-12 · Cited by 68
Shang, J., Yao, Y., Fan, X., Shangguan, L., Li, J., Liu, H., & Zhou, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.005 · Cited by 60
Cheng, R., Choudhury, D., Liu, C., Billet, S., Hu, T., & Bhowmick, N. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.46 · Cited by 56
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 69
MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells
Potter, M. L., Hill, W., Isales, C. M., Hamrick, M. W., & Fulzele, S. (2020) · Bone · doi:10.1016/j.bone.2020.115679 · Cited by 63
Kandhaya‐Pillai, R., Miró‐Mur, F., Alijotas‐Reig, J., Tchkonia, T., Schwartz, S., Kirkland, J. L., & Oshima, J. (2023) · Aging · doi:10.18632/aging.204743 · Cited by 58
Lipid Players of Cellular Senescence
Millner, A., & Atilla-Gokcumen, G. E. (2020) · Metabolites · doi:10.3390/metabo10090339 · Cited by 55
Oncogenic transformation and experimental models of human cancer
Anna, C. S. (2007) · Frontiers in bioscience · doi:10.2741/2661 · Cited by 63
Allmann, S., Mayer, L., Olma, J., Kaina, B., Hofmann, T. G., Tomicic, M. T., & Christmann, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa965 · Cited by 60
Tesei, A., Arienti, C., Bossi, G., Santi, S., Santis, I. D., Bevilacqua, A., Zanoni, M., Pignatta, S., Cortesi, M., Zamagni, A., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01883-0 · Cited by 61
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 58
Escape from senescence: molecular basis and therapeutic ramifications
Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R., & Gorgoulis, V. G. (2023) · The Journal of Pathology · doi:10.1002/path.6164 · Cited by 62
Lawrence, M., Goyal, A., Pathak, S., & Ganguly, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137411 · Cited by 63
The role of cellular senescence in ovarian aging
Hense, J. D., Isola, J. V. V., Garcia, D. N., Magalhães, L. S., Masternak, M. M., Stout, M. B., & Schneider, A. (2024) · npj Aging · doi:10.1038/s41514-024-00157-1 · Cited by 72
Surveillance mechanism linking Bub1 loss to the p53 pathway
Gjoerup, O. V., Wu, J., Chandler-Militello, D., Williams, G. L., Zhao, J., Schaffhausen, B., Jat, P. S., & Roberts, T. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703164104 · Cited by 53
Long-Term Quiescent Fibroblast Cells Transit into Senescence
Marthandan, S., Priebe, S., Hemmerich, P., Klement, K., & Diekmann, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115597 · Cited by 54
Maurelli, R., Zambruno, G., Guerra, L., Abbruzzese, C., Dimri, G. P., Gellini, M., Bondanza, S., & Dellambra, E. (2006) · The FASEB Journal · doi:10.1096/fj.05-4480fje · Cited by 56
Old cells, new tricks: chromatin structure in senescence
Parry, A. J., & Narita, M. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9628-9 · Cited by 53
Self-citationMolecular events in kidney ageing
Famulski, K. S., & Halloran, P. F. (2005) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000165890.60254.4e · Cited by 53
Neri, F., Basisty, N., Desprez, P., Campisi, J., & Schilling, B. (2021) · Current Protocols · doi:10.1002/cpz1.32 · Cited by 48
“32 INTRODUCTION Cellular senescence is a complex stress response that leads to an exit from the cell cycle that is essentially permanent, although it can in some cases be overcome by genetic or pharmacological manipulation in culture (Beausejour et al., 2003; Lee & Schmitt, 2019).”
BackgroundSelf-citationThe Importance of Physiologically Relevant Cell Lines for Studying Virus–Host Interactions
Hare, D. N., Collins, S. E., Cuddington, B., & Mossman, K. L. (2016) · Viruses · doi:10.3390/v8110297 · Cited by 63
Dynamic 3D genome reorganization during senescence: defining cell states through chromatin
Shaban, H. A., & Gasser, S. M. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01197-y · Cited by 64
Regulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo
Jackson, J. G., Post, S. M., & Lozano, G. (2011) · The Journal of Pathology · doi:10.1002/path.2783 · Cited by 53
E2F-1 is a critical modulator of cellular senescence in human cancer
Park, C., Lee, I., & Kang, W. K. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.5.715 · Cited by 61
Chondrocyte Aging: The Molecular Determinants and Therapeutic Opportunities
Ramasamy, T. S., Yee, Y. M., & Khan, I. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.625497 · Cited by 54
Immortalization of Primary Keratinocytes and Its Application to Skin Research
Choi, M., & Lee, C. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.038 · Cited by 52
Jiang, L., Liang, J., Huang, W. C., Ma, J., Park, K. H., Wu, Z., Chen, P., Zhu, H., Ma, J., Cai, W., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.015 · Cited by 52
Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by Cisplatin
Ahmadinejad, F., Bos, T., Hu, B., Britt, E., Koblinski, J. E., Souers, A. J., Leverson, J. D., Faber, A. C., Gewirtz, D. A., & Harada, H. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000354 · Cited by 57
Zou, J., Zou, P., Wang, J., Li, L., Wang, Y., Zhou, D., & Liu, L. (2012) · Annals of Hematology · doi:10.1007/s00277-011-1397-7 · Cited by 50
Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro
Prencipe, M., Fitzpatrick, P., Gorman, S., Mosetto, M., Klinger, R., Furlong, F. M., Harrison, M. J., O’Connor, D. P., Roninson, I. B., O’Sullivan, J. M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605419 · Cited by 57
Gamma rays induce a p53-independent mitochondrial biogenesis that is counter-regulated by HIF1α
Bartoletti-Stella, A., Mariani, E., Kurelac, I., Maresca, A., Caratozzolo, M. F., Iommarini, L., Carelli, V, Eusebi, L. H., Guido, A., Cenacchi, G., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.187 · Cited by 51
Significance of Cellular Senescence in Aging and Cancer
Grimes, A., & Chandra, S. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.187 · Cited by 68
Kortum, R. L., Johnson, H. J., Costanzo, D. L., Volle, D. J., Razidlo, G. L., Fusello, A. M., Shaw, A. S., & Lewis, R. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2202-2214.2006 · Cited by 61
AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11
Piscitello, D., Varshney, D., Lilla, S., Vizioli, M. G., Reid, C., Gorbunova, V. A., Seluanov, A., Gillespie, D. A., & Adams, P. D. (2017) · Oncogene · doi:10.1038/onc.2017.340 · Cited by 54
Ghashghaei, M., Paliouras, M., Heravi, M., Bekerat, H. A., Trifiro, M. A., Niazi, T. M., & Muanza, T. M. (2017) · The Prostate · doi:10.1002/pros.23445 · Cited by 55
Oroxylin A inhibits ethanol‐induced hepatocyte senescence via YAP pathway
Jin, H., Lian, N., Bian, M., Zhang, C., Chen, X., Shao, J., Wu, L., Chen, A., Guo, Q., Zhang, F., et al. (2018) · Cell Proliferation · doi:10.1111/cpr.12431 · Cited by 52
Senescent Microvesicles: A Novel Advance in Molecular Mechanisms of Atherosclerotic Calcification
Alique, M., Ramírez-Carracedo, R., Bodega, G., Carracedo, J., & Ramírez, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072003 · Cited by 53
Ding, J.-Y., Zhang, R., Li, H., Ji, Q., Cheng, X., Thorne, R. F., Hondermarck, H., Liu, X., & Shen, C. (2021) · Aging · doi:10.18632/aging.202850 · Cited by 52
IGF-I enhances cellular senescence via the reactive oxygen species–p53 pathway
Handayaningsih, A. E., Takahashi, M., Fukuoka, H., Iguchi, G., Nishizawa, H., Yamamoto, M., Suda, K., & Takahashi, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.140 · Cited by 58
Cell senescence as both a dynamic and a static phenotype
Young, A. R. J., Narita, M., & Narita, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_1 · Cited by 50
Self-citation
Metadata
- Authors
- Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Salk Institute for Biological Studies (US)
- Cold Spring Harbor Laboratory (US)
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- Venue
- The EMBO Journal
- Published
- 2003-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 4212-4222
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC175806
- OpenAlex
- W2061619522
- Cited by
- 1,457
- References
- 61
- Citations by year
- 2026: 46 · 2025: 58 · 2024: 87 · 2023: 94 · 2022: 77 · 2021: 107 · 2020: 77 · 2019: 77 · 2018: 78 · 2017: 63 · 2016: 74 · 2015: 55 · 2014: 59 · 2013: 54 · 2012: 69
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- Uehara Memorial Foundation
- National Institute on Aging (R56AG009909, R56AG016379, AG-09909, AG-16379, R01AG016379, R37AG009909)
- National Cancer Institute (P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, replicative senescence, p53, p16, retinoblastoma protein, telomere dysfunction, telomerase, oncogenic Ras, growth arrest, senescence reversal, mammary epithelial cells, fibroblasts, tumor suppression
- MeSH terms
- Breast, Cell Line, Epithelial Cells, Fibroblasts, Humans, Luminescent Proteins, Models, Biological, Genes, ras, Signal Transduction, Tumor Suppressor Protein p53, Lentivirus Infections, Cellular Senescence, Telomerase, Cyclin-Dependent Kinase Inhibitor p16, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.